0775:HKG
CK Life Sciences Intl (Holdings) Inc
HK$0.51
arrow_downward
-1.92%(-0.0100) 1H
15 Okt, 4:08:33 PTG GMT+8 · HKD
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk 0775...
Buka
HK$0.52
Tinggi
HK$0.52
Rendah
HK$0.51
Permodalan Pasaran
4.86B
Purata volum
1.64J
Volum
1.49J
tgi 52 mgu
HK$1.02
rdh 52 mgu
HK$0.51
EPS
-HK$0.01
Syer tertunggak
9.61B
Bilangan pekerja
2K
Buka
HK$0.52
Tinggi
HK$0.52
Rendah
HK$0.51
Permodalan Pasaran
4.86B
Purata volum
1.64J
Volum
1.49J
tgi 52 mgu
HK$1.02
rdh 52 mgu
HK$0.51
EPS
-HK$0.01
Syer tertunggak
9.61B
Bilangan pekerja
2K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Astro Awani
·
17 jam lalu
S&P 500: Wall Street market update | 15 October 2026
Invezz
·
3 hari lalu
Dow Jones dibuka 190 mata lebih tinggi, pelabur memerhati pendapatan bank dan inflasi
Invezz
·
2 hari lalu
Dow naik 198 mata, saham AS bercampur menjelang keputusan pendapatan
Invezz
·
1 hari lalu
Dow ditutup 170 mata lebih rendah ketika penjualan saham cip berterusan
Profil
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Victor Li Tzar-kuoi, the eldest son of Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.
CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector.
The company divested its Canadian subsidiary WEX Pharmaceuticals to Virios Therapeutics for $100 million in October 2024. Wikipedia
Perihal CK Life Sciences Intl (Holdings) Inc